We Should Not Forget About Patients With Inflammatory Bowel Disease Who Received a COVID-19 Viral Vector Vaccine.

Lutz, Megan; Hayney, Mary S; Caldera, Freddy

Lutz, Megan; Hayney, Mary S; Caldera, Freddy.

Lutz M; Department of Medicine, Division of Gastroenterology and Hepatology, University of Wisconsin-Madison, School of Medicine and Public Health, Madison, Wisconsin, USA.
Hayney MS; School of Pharmacy, University of Wisconsin-Madison, School of Medicine and Public Health, Madison, Wisconsin, USA.
Caldera F; Department of Medicine, Division of Gastroenterology and Hepatology, University of Wisconsin-Madison, School of Medicine and Public Health, Madison, Wisconsin, USA.

Am J Gastroenterol ; 117(8): 1329, 2022 08 01.

Article in English | MEDLINE | ID: covidwho-1791675

Subject(s)

COVID-19 Vaccines; COVID-19; Inflammatory Bowel Diseases; COVID-19/prevention & control; COVID-19 Vaccines/administration & dosage; Humans; Inflammatory Bowel Diseases/therapy; SARS-CoV-2

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Inflammatory Bowel Diseases / COVID-19 Vaccines / COVID-19 Topics: Vaccines Limits: Humans Language: English Journal: Am J Gastroenterol Year: 2022 Document Type: Article Affiliation country: Ajg.0000000000001791

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google